Ruling Out Other Conditions Diagnosing gastroparesis also means checking for other conditions that might cause similar symptoms
Glycemic indexes (A1C, fasting blood glucose) and kidney function should be monitored during initiation of therapy and routinely throughout the treatment plan
By slowing gastric emptying of a liquid or solid meal, GLP-1 reduces the postprandial demand of insulin to maintain euglycemia after a meal (77, 78)
In post hoc analyses of the randomised clinical controlled LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) trial, patients assigned to GLP-1RAs (liraglutide) had a reduced risk of prostate cancer (HR 0.54, 95% CI 0.34, 0.88) compared with patients assigned to placebo in addition to standard care
Combined with baseline biomarkers like fasting insulin, glucose tolerance, and lipid patterns, this context can support discussion of whether the cheapest option is also the best fit for your unique physiology